(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer (clinicaltrials.gov) - Oct 27, 2026 - P1 | N=20 | Active, not recruiting | Sponsor: Weill Medical College of Cornell University | Trial completion date: Dec 2026 ➔ May 2027
Trial completion date • Bladder Cancer • Genito-urinary Cancer • Oncology • Solid Tumor • Urothelial Cancer
|